New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D.
A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms ...
A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms ...
Each June, America celebrates PTSD Awareness Month. More than any year in recent memory, those suffering from this invisible disorder ...
Following the SARS virus outbreak in 2003, various studies detailed increased cases of depression and post-traumatic stress disorder. As the ...
With more research on the horizon, those suffering with severe depression may find reprieve in ketamine and cannabis. Used for ...
A small study hints at how ketamine interacts with serotonin. The anesthetic ketamine shows promise as a rapid treatment for ...
A team of scientists at Cambridge may have accidentally discovered why k-holes feel so much like near-death experiences. A team ...
A new study has identified how ketamine can combat difficult-to-treat depression. New research has revealed the specific parts of the ...
Despite the fact that most non-COVID medical research and funding has come to a halt during the pandemic, there is ...
The American Society of Ketamine Physicians (ASKP) was formed in 2016 after the original founders met at the KRIYA conference ...
© 2025 Ketamine News